These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2521197)

  • 21. At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled.
    Huntington Study Group PHAROS Investigators
    Arch Neurol; 2006 Jul; 63(7):991-6. PubMed ID: 16831969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
    Lancet; 2000 Apr; 355(9210):1131-7. PubMed ID: 10791375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up.
    Glynn JR; Sonnenberg P; Nelson G; Bester A; Shearer S; Murray J
    AIDS; 2007 Mar; 21(5):625-32. PubMed ID: 17314525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
    Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
    Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion.
    Geskus RB
    Stat Med; 2000 Jul; 19(13):1753-69. PubMed ID: 10861776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Huntington disease: estimation of heterozygote status using linked genetic markers.
    Conneally PM; Wallace MR; Gusella JF; Wexler NS
    Genet Epidemiol; 1984; 1(1):81-8. PubMed ID: 6242401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington's disease.
    Hu Y; Liang J; Yu S
    J Alzheimers Dis; 2014; 40(4):863-8. PubMed ID: 24531153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk.
    Fisher ER; Hayden MR
    Mov Disord; 2014 Jan; 29(1):105-14. PubMed ID: 24151181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetic model for age at onset in Huntington disease.
    Farrer LA; Conneally PM
    Am J Hum Genet; 1985 Mar; 37(2):350-7. PubMed ID: 3157315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic heterogeneity in Huntington disease.
    Folstein SE; Abbott MH; Franz ML; Huang S; Chase GA; Folstein MF
    J Neurogenet; 1984 Apr; 1(2):175-84. PubMed ID: 6242167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.
    Laga M; Manoka A; Kivuvu M; Malele B; Tuliza M; Nzila N; Goeman J; Behets F; Batter V; Alary M
    AIDS; 1993 Jan; 7(1):95-102. PubMed ID: 8442924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to HIV infection and AIDS in Italian haemophiliacs is HLA associated.
    Fabio G; Smeraldi RS; Gringeri A; Marchini M; Bonara P; Mannucci PM
    Br J Haematol; 1990 Aug; 75(4):531-6. PubMed ID: 2207004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of morbid risk and age at onset with missing information.
    Cupples LA; Risch N; Farrer LA; Myers RH
    Am J Hum Genet; 1991 Jul; 49(1):76-87. PubMed ID: 1829582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of the age at onset of Huntington's disease from factors associated with the affected parent.
    Brackenridge CJ; Teltscher B
    J Med Genet; 1975 Mar; 12(1):64-9. PubMed ID: 123590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huntington's disease does not appear to increase the risk of diabetes mellitus.
    Boesgaard TW; Nielsen TT; Josefsen K; Hansen T; Jørgensen T; Pedersen O; Nørremølle A; Nielsen JE; Hasholt L
    J Neuroendocrinol; 2009 Sep; 21(9):770-6. PubMed ID: 19602103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis of Huntington disease in Italy.
    Ajmar F; Mandich P; Bellone E; Abbruzzese G
    Am J Med Genet; 1991 May; 39(2):211-4. PubMed ID: 1829583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression.
    Alcabes P; Pezzotti P; Phillips AN; Rezza G; Vlahov D
    Am J Epidemiol; 1997 Oct; 146(7):543-51. PubMed ID: 9326431
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.